Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Cantor Fitzgerald raised their FY2025 earnings per share estimates for shares of Beam Therapeutics in a research report issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback